Healthcare Data Monetization Solutions Market Size & Share 2025 to 2034
Market Size by Type, by Deployment type, by Application, by Data Type, by End Use, Global Forecast.
Download Free PDF
Market Size by Type, by Deployment type, by Application, by Data Type, by End Use, Global Forecast.
Download Free PDF
Starting at: $2,450
Base Year: 2024
Companies Profiled: 15
Tables & Figures: 151
Countries Covered: 19
Pages: 140
Download Free PDF
Healthcare Data Monetization Solutions Market
Get a free sample of this report
Healthcare Data Monetization Solutions Market Size
The global healthcare data monetization solutions market size was valued at USD 998.3 million in 2024 and is estimated to grow at 18.2% CAGR from 2025 to 2034. The evolution of healthcare data monetization around the world is limited only by the development of new digital platforms and collaborations between technology companies and medical institutions.
Healthcare Data Monetization Solutions Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
For example, in 2024, Mayo Clinic used anonymized patient records for clinical research initiatives after integrating its three proprietary data pipelines: CloudMetrics, InsightFlow, and PrecisionXchange. Additionally, Cleveland Clinic captured seven data-sharing borderless specialized projects in the field of genomics. Moreover, Stanford Medicine initiated at least nine clinical trial programs to which an AI-based clinical trial optimization analytics application was provided.
The growing adoption of electronic health records (EHRs) is likely to fuel growth in the market. EHR is the set of information of a patient stored electronically, including details such as diagnosis, case history, medication history, and treatment given. EHR serves as one of the primary requirements in the healthcare data monetization chain for functions such as medical research, constructing new drugs, and developing clinical trials programs. For instance, based on a survey held in June 2023 by the insurance company Munich Re Group from Germany, around 90% of insurers claimed that they actively utilize EHRs, which shows a 38% increase since 2020.
The boost in the use of technology in healthcare systems comes as a vital factor in the growth of the market for healthcare data monetization solutions. One of the big changes anticipated to occur in the particular period is improving the level of attention to security and privacy, the growth of data exchange platforms, the increased proliferation of value-based care models, the application of AI and machine learning, as well as the creation of data monetization alliances. All of these anticipations are likely to affect the trends in the infrastructure of healthcare data monetization solutions.
Healthcare Data Monetization Solutions Market Trends
Healthcare Data Monetization Solutions Market Analysis
In 2021, the global market was valued at USD 616.8 million. The following year, it saw a slight increase to USD 723.5 million, and by 2023, the market further climbed to USD 849.5 million. Based on the type, the market is divided into direct data monetization and indirect data monetization. The direct data monetization segment is projected to grow at a 19.4% CAGR throughout the forecast period.
Based on the deployment type, the cloud segment dominated the healthcare data monetization solutions market. In 2024, the cloud-based solutions captured a revenue share of 70.2%, a trend expected to continue in the coming years.
Based on data type, the healthcare data monetization solutions market is bifurcated into clinical data, claims data, EHR data, and genomic data. In 2024, the clinical data segment represented a 24.5% revenue share and the EHR segment has the highest growth of 18.8%.
Based on end use, the market is bifurcated into pharmaceutical and biotechnology companies, healthcare payers, healthcare providers, medical technology companies, and other end users. In 2024, pharmaceutical and biotechnology companies accounted for a substantial portion of the revenue, reaching USD 208.2 million.
The U.S. healthcare data monetization solutions market was valued at USD 241.3 million in 2021. The country dominated the North American market in 2023 with USD 325.6 million growing from USD 280.2 million in 2022.
In the Europe region, the healthcare data monetization solutions market in UK is expected to experience significant and promising growth from 2025 to 2034.
Japan is poised to see the swiftest growth in the Asia-Pacific healthcare data monetization solutions market from 2025 to 2034.
In the Latin America region, the healthcare data monetization solutions market in Mexico is expected to grow faster than in other countries during the period from 2025 to 2034.
In the MEA region, the healthcare data monetization solutions market in UAE market holds a significant share than other countries.
Healthcare Data Monetization Solutions Market Share
Accenture, IBM, and Optum together command over 35% of the competitive market, which features both large global players and nimble smaller firms. Companies are bolstering their global market value by heavily investing in advanced AI technologies. Collaborating with healthcare providers and research institutions is vital for these companies to seamlessly integrate innovations and broaden their market reach. Furthermore, regulatory backing and expedited approval processes are accelerating the adoption of new technologies, catering to the surging demand for EHR-based data solutions. Collectively, these elements fortify companies' standings in the burgeoning market.
Healthcare Data Monetization Solutions Market Companies
Some of the eminent market participants operating in the healthcare data monetization solutions industry include:
Healthcare Data Monetization Solutions Market News:
The healthcare data monetization solutions market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:
Click here to Buy Section of this Report
Market, By Type
Market, By Deployment Type
Market, By Application
Market, By Data Type
Market, By End Use
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →